Frank Yocca, Chief Scientific Officer: BioXcel Therapeutics BTAIQ Sell · Filed 05/22

Trade details

Type: Insider sale
Amount: $7,461.05
Shares · price: 6,845 sh · $1.09 a share
Held after: 26,175 sh
Stock: BioXcel Therapeutics BTAIQ
Person: Frank YoccaChief Scientific Officer
Trade date: 26/05/20
Filed: 26/05/22
Days to filing: 2 days

Sold 20.7% of holdings

Share of holding sold: 20.7%

BioXcel Therapeutics trades, last 26 weeks

What else happened in BioXcel Therapeutics around then

Filed or reported within 30 days of the trade day · 04/20~06/19

Frank Yocca's recent trades

Frank YoccaChief Scientific Officer
Planned sale10b5-1 planBioXcel Therapeutics
Planned sale10b5-1 plan
BioXcel Therapeutics
BTAIQ
$7,430
6,845 sh
$7,430
Filed 05/20
Traded 05/20
Frank YoccaChief Scientific Officer
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$79
225 sh
$79
Filed 24/12/17
Traded 24/12/16
Frank YoccaChief Scientific Officer
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$74
205 sh
$74
Filed 24/12/17
Traded 24/12/16
Frank YoccaChief Scientific Officer
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$3,946
7,175 sh
$3,946
Filed 24/10/03
Traded 24/10/03
Frank YoccaChief Scientific Officer
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$245
355 sh
$245
Filed 24/09/17
Traded 24/09/16

Frank Yocca, Chief Officer — sold $7,461 of BioXcel Therapeutics BTAIQ · 20.7% of holdings · 10b5-1 plan | Whalegun